Raves, Danielle M.
Herrera, Wynetta D.
Darnell, Matthew E.
Rice, Tristan
Friedman, Craig
Moratti, Stephanie C.
Sims, Stacy T.
Sihanath, Wandasun B.
Ehrhardt, Shannon N.
Phillips, Amanda
Funding for this research was provided by:
Exos
Article History
Received: 5 September 2024
Accepted: 29 May 2025
First Online: 30 August 2025
Declarations
:
: This study protocol (Pro00069622) was submitted to and exempt by Advarra, an independent institutional review board (IRB). This study protocol was exempt from IRB oversight on March 29, 2023, using the Department of Health and Human Services regulations found at 45CFR46. 104(d) [2]. The study was conducted in accordance with the Declaration of Helsinki and all relevant regulatory guidelines. Written informed consent was obtained from all study participants. Participation in this study was voluntary, and participants were able to withdraw from completing the survey at any time.
: Not applicable.
: DMR, WDH, MED, TR, CF, SCM, WBS, SNE, AP are current or recent (within the past 5 years) employees of Exos. STS is a consultant for Exos.
: Funding for this study was provided by Exos, Phoenix, AZ, USA.